Molly E. Collins, MD, Joins the Fox Chase–Temple University Hospital Pain and Palliative Care Program

PHILADELPHIA (July 25, 2016) — Molly E. Collins, MD, has joined the department of hematology/oncology at Fox Chase Cancer Center, providing additional physician support for the Fox Chase Cancer Center – Temple University Hospital Pain and Palliative Care Program.

“We’re very excited to welcome Dr. Collins into the Pain and Palliative Care Program. Her experience and wealth of knowledge in palliative medicine will help us to deliver the best supportive care to our patients. Dr. Collins will also be an asset to our growing group of first-rate physicians. We are thrilled she will be joining our multidisciplinary team of clinicians,” said Marcin Chwistek, MD, FAAHPM, director of the program.

Collins is a licensed, board-certified physician. After earning her medical degree at Harvard Medical School, Collins worked as an intern and resident at the Hospital of the University of Pennsylvania, and later as a clinical assistant professor of medicine at Thomas Jefferson University Hospital in Philadelphia. Collins is currently completing a fellowship at Harvard Medical School in their Interprofessional Palliative Care Program. Her start date at Fox Chase will be August 1, 2016.

“I am truly honored to be joining such a dedicated team of clinicians and researchers at Fox Chase Cancer Center,” Collins said. “I look forward to working with Dr. Chwistek to advance the practice of palliative care and to support the best possible quality of life for patients at Fox Chase and for their families.”

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text